Monopar Therapeutics Inc (MNPR)
SG&A Expense Growth
-99.89%
Quarterly · Period ending:
MNPR SG&A Expense Growth
Latest reported-99.89%period ending
Latest reported-99.89%period ending
MNPR Quarterly SG&A Growth (QoQ) (0.00% → -99.89%)
Latest values, visible window
High-resolution chart · PNG
MNPR sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -99.892% | |
| 78,396.22% | |
| 47.2819% | |
| -0.0644% | |
| -4.6975% | |
| 37.253% | |
| 94.7134% | |
| -10.213% | |
| -13.1358% | |
| -13.5916% | |
| 16.9349% | |
| 2.1783% | |
| -15.8521% | |
| 8.1442% | |
| 19.3915% | |
| -1.4254% | |
| -12.1112% | |
| 11.5705% | |
| 10.5657% | |
| 2.5542% | |
| -10.4619% | |
| 9.4782% | |
| 60.2745% | |
| -37.9283% | |
| -20.2093% | |
| 23.4731% | |
| 18.8129% | |
| -10.4863% | |
| 5.4409% | |
| 19.8574% | |
| 31.0962% | |
| 4.7497% | |
| -21.0782% | |
| 2.9554% | |
| 98.615% | |
| -24.0436% | |
| 18.0177% | |
| 7.0483% | |
| 75.6923% | |
| -54.448% | |
| -0.0004% | |
| 0% |